Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × spartalizumab × Gynecologic × Clear all

Phase

Status

Terminated 4 Completed 4 Recruiting 3 Active not recruiting 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 22 Lymphoid 8 Head & Neck 5 Thoracic 4 Other solid neoplasm 4 Tumor-Agnostic 2 Breast 2 Sarcoma 1 Gynecologic 1 Genitourinary 1 Dermatologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 69 Carboplatin 67 Cisplatin 64 Radiotherapy 25 Bevacizumab 25 Brachytherapy 20 olaparib 18 Drug Therapy 18 Gemcitabine 16 niraparib 15 apatinib 15 pembrolizumab 14 Hyperthermic Intraperitoneal Chemotherapy 14 Surgical Procedures, Operative 12 liposomal doxorubicin 11 Cyclophosphamide 11 Etoposide 9 fludarabine 8 anlotinib 8 Taxes 8 Surveys and Questionnaires 8 Neoadjuvant Therapy 8 Docetaxel 8 Blood Specimen Collection 8 camrelizumab 7 Topotecan 7 durvalumab 6 Sentinel Lymph Node Biopsy 6 Radiotherapy, Intensity-Modulated 6 Platinum 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04368273 2020-04-29

CCRT+PD-1

Peking University Third Hospital

Phase 1/2 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡